AACR Virtual Annual Meeting 2020 II: MSK Research Shows That Young Adults With Early-Onset Cancer Are at High Risk of Harboring Inherited Genetic Mutations
June 23, 2020
June 23, 2020
NEW YORK, June 23 -- The Memorial Sloan Kettering Cancer Center issued the following news release:
A study from Memorial Sloan Kettering (MSK) found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations. Results from this study were presented by Zsofia K. Stadler, MD, medical oncologist at MSK, on June 19 during a media preview of the American Association for Cancer Research (AACR) Virtual Annual Me . . .
A study from Memorial Sloan Kettering (MSK) found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations. Results from this study were presented by Zsofia K. Stadler, MD, medical oncologist at MSK, on June 19 during a media preview of the American Association for Cancer Research (AACR) Virtual Annual Me . . .